Medicare Enrolled
Dr. Kenneth Wogensen, MD
Neurology · Arcadia, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wogensen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wogensen?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wogensen
Dr. Kenneth Wogensen is a neurology specialist in Arcadia, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wogensen performed 3,047 Medicare services across 1,553 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wogensen received a total of $25,301 from 93 pharmaceutical and/or device companies across 1230 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wogensen is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in CA
$25,301 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,047
Medicare services
Top 18% in CA for neurology
1,553
Unique beneficiaries
$124
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~152 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,023 | $107 | $145 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
472 | $88 | $120 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
391 | $66 | $90 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
195 | $403 | $550 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
182 | $183 | $260 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
177 | $103 | $200 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
141 | $100 | $150 |
| Auditory brainstem response test A test that measures how the brain responds to sound to help diagnose nervous system disorders. The results are interpreted and reported by a medical professional. |
133 | $72 | $115 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
108 | $144 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
92 | $137 | $220 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
44 | $219 | $300 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
35 | $109 | $225 |
| Visual evoked potential test A test that measures how quickly electrical signals travel from the eye to the brain in response to visual stimuli. |
30 | $59 | $120 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
12 | $88 | $130 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
12 | $253 | $365 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$25,301
Total received (2018-2024)
Avg $3,614/year across 7 years
Top 13% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
93
Companies
1,230
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,113 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$188 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,092
2023
$3,761
2022
$3,917
2021
$3,838
2020
$2,820
2019
$3,795
2018
$3,078
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Eisai Inc.
$560
Biogen, Inc.
$453
ABBVIE INC.
$429
Alexion Pharmaceuticals, Inc.
$330
Novartis Pharmaceuticals Corporation
$317
PFIZER INC.
$305
UCB, Inc.
$241
ACADIA Pharmaceuticals Inc
$221
MDD US Operations, LLC
$167
Ipsen Biopharmaceuticals, Inc
$135
Celgene Corporation
$132
Lilly USA, LLC
$104
Neurocrine Biosciences, Inc.
$90
Teva Pharmaceuticals USA, Inc.
$65
Amneal Pharmaceuticals LLC
$62
CATALYST PHARMACEUTICALS, INC.
$62
Amgen Inc.
$57
Mallinckrodt Hospital Products Inc.
$49
TG Therapeutics, Inc.
$48
EMD Serono, Inc.
$45
Lundbeck LLC
$38
Neurelis, Inc.
$37
Genentech USA, Inc.
$35
JAZZ PHARMACEUTICALS INC.
$27
ARGENX US, INC.
$27
Avadel CNS Pharmaceuticals, LLC
$22
Otsuka America Pharmaceutical, Inc.
$19
SCILEX PHARMACEUTICALS INC.
$14
Top 3 companies account for 35.2% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$2,091
Biogen, Inc.
$1,911
Novartis Pharmaceuticals Corporation
$1,689
Teva Pharmaceuticals USA, Inc.
$1,517
ACADIA Pharmaceuticals Inc
$1,385
Alexion Pharmaceuticals, Inc.
$1,190
Amgen Inc.
$993
GENZYME CORPORATION
$878
Lilly USA, LLC
$801
ABBVIE INC.
$721
Eisai Inc.
$667
PFIZER INC.
$650
Sunovion Pharmaceuticals Inc.
$622
Lundbeck LLC
$600
AbbVie Inc.
$572
EMD Serono, Inc.
$518
Avanir Pharmaceuticals, Inc.
$515
Amneal Pharmaceuticals LLC
$464
Celgene Corporation
$331
Allergan, Inc.
$320
Grifols USA, LLC
$314
Abbott Laboratories
$313
Acorda Therapeutics, Inc
$301
Neurocrine Biosciences, Inc.
$285
JAZZ PHARMACEUTICALS INC.
$270
Alnylam Pharmaceuticals Inc.
$231
Biohaven Pharmaceutical Holding Company Ltd.
$229
Greenwich Biosciences, Inc.
$215
Takeda Pharmaceuticals U.S.A., Inc.
$214
Merz Pharmaceuticals, LLC
$214
MDD US Operations, LLC
$198
Otsuka America Pharmaceutical, Inc.
$193
Ipsen Biopharmaceuticals, Inc
$192
CSL Behring
$189
Adamas Pharmaceuticals, Inc.
$187
Jazz Pharmaceuticals Inc.
$171
Allergan Inc.
$163
US WorldMeds, LLC
$160
Merck Sharp & Dohme Corporation
$151
AQUESTIVE THERAPEUTICS, INC.
$129
Biohaven Pharmaceuticals, Inc.
$127
Corium, LLC
$119
Almatica Pharma LLC
$117
Supernus Pharmaceuticals, Inc.
$107
Kyowa Kirin, Inc.
$106
Horizon Therapeutics plc
$101
NOVARTIS PHARMACEUTICALS CORPORATION
$100
Medtronic USA, Inc.
$87
Mallinckrodt Hospital Products Inc.
$82
CATALYST PHARMACEUTICALS, INC.
$82
Neurelis, Inc.
$75
Janssen Pharmaceuticals, Inc
$70
Zyla Life Sciences, Inc.
$70
SK Life Science, Inc.
$68
EISAI INC.
$67
Zogenix Inc.
$65
Vertical Pharmaceuticals, LLC
$60
Marinus Pharmaceuticals, Inc.
$56
MITSUBISHI TANABE PHARMA AMERICA, INC.
$55
Mallinckrodt Enterprises LLC
$48
TG Therapeutics, Inc.
$48
PORTOLA PHARMACEUTICALS, INC.
$46
Mallinckrodt LLC
$45
Promius Pharma LLC
$45
Assertio Therapeutics, Inc.
$44
ARGENX US, INC.
$43
Akcea Therapeutics, Inc.
$43
IMPEL PHARMACEUTICALS INC.
$38
Impax Laboratories, Inc.
$37
Medtronic, Inc.
$35
LivaNova USA, Inc.
$35
Genentech USA, Inc.
$35
Azurity Pharmaceuticals, Inc.
$30
Bausch Health US, LLC
$26
Mitsubishi Tanabe Pharma America, Inc.
$24
Catalyst Pharmaceuticals, Inc.
$23
E.R. Squibb & Sons, L.L.C.
$23
Sumitomo Pharma America, Inc.
$22
Avadel CNS Pharmaceuticals, LLC
$22
Banner Life Sciences, LLC
$21
Octapharma USA, Inc.
$21
Electromed, Inc.
$21
SANOFI-AVENTIS U.S. LLC
$20
ASSERTIO THERAPEUTICS, Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$18
Collegium Pharmaceutical, Inc.
$17
Pernix Therapeutics Holdings, Inc.
$16
Arbor Pharmaceuticals, Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$16
Zyla Life Sciences
$14
SCILEX PHARMACEUTICALS INC.
$14
Travere Therapeutics, Inc.
$6
Retrophin, Inc.
$1
Top 3 companies account for 22.5% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ACTIVA · ADLARITY · ADUHELM · AGAMREE · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CAMBIA · COMIRNATY · COPAXONE · CREXONT · Cholbam · DAYBUE · DUOPA · Dysport · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · EXSERVAN · Edarbyclor · Epidiolex · Eprontia · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · Gralise · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LINZESS · LUMRYZ · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MS DISEASE STATE · MYOBLOC · Mavenclad · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · OSMOLEX ER · Ocrevus · Ongentys · PANZYGA · PAXLOVID · Ponvory · QALSODY · QULIPTA · RADICAVA · REXULTI · REYVOW · RYTARY · Radicava · Rebif · Repatha · Reveal LINQ · Rystiggo · SILENOR · SMARTVEST · SOLIRIS · SPRIX · SYMPAZAN · Soliris · TEGSEDI · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · Vimpat · XARELTO · XYREM · XYWAV · Xadago · Xembify · Xeomin · Xyrem · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTALMY · ZTLido · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
477
Per 100K population
4.8
County median income
$87,760
Nearest hospital
USC ARCADIA HOSPITAL
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wogensen is a clinical cardiology specialist, with above-average Medicare volume (top 18% in CA), with low-engagement industry engagement in the top 13% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wogensen experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Wogensen performed 1,023 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wogensen receive payments from pharmaceutical companies?
Yes. Dr. Wogensen received a total of $25,301 from 93 companies across 1,230 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wogensen's costs compare to other neurologists in Arcadia?
Dr. Wogensen's average Medicare payment per service is $124. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wogensen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Arcadia
Browse neurologists in Arcadia ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology